M. H. ALBANJI, S. H. SURBAYA, and O. A. ALNAKHLI, “IMMUNOPATHOGENESIS AND EMERGING IMMUNOTHERAPIES IN TYPE 1 DIABETES MELLITUS: THE ROLE OF TEPLIZUMAB IN DISEASE MODULATION”, TPM, vol. 32, no. S1 (2025): Posted 12 May, pp. 738–744, Aug. 2025.